Abstract
MYD88 (myeloid differentiation primary response 88) is mutated in the majority of Waldenstrom macroglobulinemia/lymphoplasmacytic lymphoma (LPL); but ......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
